Using a short-amplicon qPCR assay, we demonstrated for the first time, the detection of CTNNB1 mutations in urine of HCC patients, and the prognostic utility of mutated CTNNB1 in postoperative urine for HCC patients whose urine contained such mutations before surgery. Here, CTNNB1 is linked to hepatocellular carcinoma.